Global Pulmonary Drug Delivery Devices/Systems Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Pulmonary Drug Delivery Devices/Systems will have significant change from previous year. According to our (LP Information) latest study, the global Pulmonary Drug Delivery Devices/Systems market size is USD million in 2022 from USD 2735.7 million in 2021, with a change of % between 2021 and 2022. The global Pulmonary Drug Delivery Devices/Systems market size will reach USD 3687.3 million in 2028, growing at a CAGR of 4.4% over the analysis period.
The United States Pulmonary Drug Delivery Devices/Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pulmonary Drug Delivery Devices/Systems market, reaching US$ million by the year 2028. As for the Europe Pulmonary Drug Delivery Devices/Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pulmonary Drug Delivery Devices/Systems players cover Hovione, 3M Health Care, Bespak, and BeyonDevices, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Devices/Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Pulmonary Drug Delivery Devices/Systems will have significant change from previous year. According to our (LP Information) latest study, the global Pulmonary Drug Delivery Devices/Systems market size is USD million in 2022 from USD 2735.7 million in 2021, with a change of % between 2021 and 2022. The global Pulmonary Drug Delivery Devices/Systems market size will reach USD 3687.3 million in 2028, growing at a CAGR of 4.4% over the analysis period.
The United States Pulmonary Drug Delivery Devices/Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pulmonary Drug Delivery Devices/Systems market, reaching US$ million by the year 2028. As for the Europe Pulmonary Drug Delivery Devices/Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pulmonary Drug Delivery Devices/Systems players cover Hovione, 3M Health Care, Bespak, and BeyonDevices, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Devices/Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Accessories
- Hospitals and Clinics
- Homecare
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hovione
- 3M Health Care
- Bespak
- BeyonDevices
- GlaxoSmithKline
- H&T Presspart
- PARI Respiratory Equipment
- Philips Respironics
- SHL
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pulmonary Drug Delivery Devices/Systems by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pulmonary Drug Delivery Devices/Systems by Country/Region, 2017, 2022 & 2028
2.2 Pulmonary Drug Delivery Devices/Systems Segment by Type
2.2.1 Metered Dose Inhalers
2.2.2 Dry Powder Inhalers
2.2.3 Nebulizers
2.2.4 Accessories
2.3 Pulmonary Drug Delivery Devices/Systems Sales by Type
2.3.1 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
2.3.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pulmonary Drug Delivery Devices/Systems Sale Price by Type (2017-2022)
2.4 Pulmonary Drug Delivery Devices/Systems Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Homecare
2.5 Pulmonary Drug Delivery Devices/Systems Sales by Application
2.5.1 Global Pulmonary Drug Delivery Devices/Systems Sale Market Share by Application (2017-2022)
2.5.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pulmonary Drug Delivery Devices/Systems Sale Price by Application (2017-2022)
3 GLOBAL PULMONARY DRUG DELIVERY DEVICES/SYSTEMS BY COMPANY
3.1 Global Pulmonary Drug Delivery Devices/Systems Breakdown Data by Company
3.1.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales by Company (2020-2022)
3.1.2 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2020-2022)
3.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue by Company (2020-2022)
3.2.1 Global Pulmonary Drug Delivery Devices/Systems Revenue by Company (2020-2022)
3.2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Company (2020-2022)
3.3 Global Pulmonary Drug Delivery Devices/Systems Sale Price by Company
3.4 Key Manufacturers Pulmonary Drug Delivery Devices/Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Drug Delivery Devices/Systems Product Location Distribution
3.4.2 Players Pulmonary Drug Delivery Devices/Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PULMONARY DRUG DELIVERY DEVICES/SYSTEMS BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Drug Delivery Devices/Systems Market Size by Geographic Region (2017-2022)
4.1.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue by Geographic Region
4.2 World Historic Pulmonary Drug Delivery Devices/Systems Market Size by Country/Region (2017-2022)
4.2.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue by Country/Region
4.3 Americas Pulmonary Drug Delivery Devices/Systems Sales Growth
4.4 APAC Pulmonary Drug Delivery Devices/Systems Sales Growth
4.5 Europe Pulmonary Drug Delivery Devices/Systems Sales Growth
4.6 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Drug Delivery Devices/Systems Sales by Country
5.1.1 Americas Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022)
5.1.2 Americas Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022)
5.2 Americas Pulmonary Drug Delivery Devices/Systems Sales by Type
5.3 Americas Pulmonary Drug Delivery Devices/Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Drug Delivery Devices/Systems Sales by Region
6.1.1 APAC Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022)
6.1.2 APAC Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022)
6.2 APAC Pulmonary Drug Delivery Devices/Systems Sales by Type
6.3 APAC Pulmonary Drug Delivery Devices/Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Drug Delivery Devices/Systems by Country
7.1.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022)
7.1.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022)
7.2 Europe Pulmonary Drug Delivery Devices/Systems Sales by Type
7.3 Europe Pulmonary Drug Delivery Devices/Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Drug Delivery Devices/Systems by Country
8.1.1 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022)
8.2 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Type
8.3 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices/Systems
10.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices/Systems
10.4 Industry Chain Structure of Pulmonary Drug Delivery Devices/Systems
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Drug Delivery Devices/Systems Distributors
11.3 Pulmonary Drug Delivery Devices/Systems Customer
12 WORLD FORECAST REVIEW FOR PULMONARY DRUG DELIVERY DEVICES/SYSTEMS BY GEOGRAPHIC REGION
12.1 Global Pulmonary Drug Delivery Devices/Systems Market Size Forecast by Region
12.1.1 Global Pulmonary Drug Delivery Devices/Systems Forecast by Region (2023-2028)
12.1.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pulmonary Drug Delivery Devices/Systems Forecast by Type
12.7 Global Pulmonary Drug Delivery Devices/Systems Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hovione
13.1.1 Hovione Company Information
13.1.2 Hovione Pulmonary Drug Delivery Devices/Systems Product Offered
13.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hovione Main Business Overview
13.1.5 Hovione Latest Developments
13.2 3M Health Care
13.2.1 3M Health Care Company Information
13.2.2 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Offered
13.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 3M Health Care Main Business Overview
13.2.5 3M Health Care Latest Developments
13.3 Bespak
13.3.1 Bespak Company Information
13.3.2 Bespak Pulmonary Drug Delivery Devices/Systems Product Offered
13.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bespak Main Business Overview
13.3.5 Bespak Latest Developments
13.4 BeyonDevices
13.4.1 BeyonDevices Company Information
13.4.2 BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Offered
13.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BeyonDevices Main Business Overview
13.4.5 BeyonDevices Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Offered
13.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 H&T Presspart
13.6.1 H&T Presspart Company Information
13.6.2 H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Offered
13.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 H&T Presspart Main Business Overview
13.6.5 H&T Presspart Latest Developments
13.7 PARI Respiratory Equipment
13.7.1 PARI Respiratory Equipment Company Information
13.7.2 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Offered
13.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PARI Respiratory Equipment Main Business Overview
13.7.5 PARI Respiratory Equipment Latest Developments
13.8 Philips Respironics
13.8.1 Philips Respironics Company Information
13.8.2 Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Offered
13.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Philips Respironics Main Business Overview
13.8.5 Philips Respironics Latest Developments
13.9 SHL
13.9.1 SHL Company Information
13.9.2 SHL Pulmonary Drug Delivery Devices/Systems Product Offered
13.9.3 SHL Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SHL Main Business Overview
13.9.5 SHL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pulmonary Drug Delivery Devices/Systems by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pulmonary Drug Delivery Devices/Systems by Country/Region, 2017, 2022 & 2028
2.2 Pulmonary Drug Delivery Devices/Systems Segment by Type
2.2.1 Metered Dose Inhalers
2.2.2 Dry Powder Inhalers
2.2.3 Nebulizers
2.2.4 Accessories
2.3 Pulmonary Drug Delivery Devices/Systems Sales by Type
2.3.1 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
2.3.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pulmonary Drug Delivery Devices/Systems Sale Price by Type (2017-2022)
2.4 Pulmonary Drug Delivery Devices/Systems Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Homecare
2.5 Pulmonary Drug Delivery Devices/Systems Sales by Application
2.5.1 Global Pulmonary Drug Delivery Devices/Systems Sale Market Share by Application (2017-2022)
2.5.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pulmonary Drug Delivery Devices/Systems Sale Price by Application (2017-2022)
3 GLOBAL PULMONARY DRUG DELIVERY DEVICES/SYSTEMS BY COMPANY
3.1 Global Pulmonary Drug Delivery Devices/Systems Breakdown Data by Company
3.1.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales by Company (2020-2022)
3.1.2 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2020-2022)
3.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue by Company (2020-2022)
3.2.1 Global Pulmonary Drug Delivery Devices/Systems Revenue by Company (2020-2022)
3.2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Company (2020-2022)
3.3 Global Pulmonary Drug Delivery Devices/Systems Sale Price by Company
3.4 Key Manufacturers Pulmonary Drug Delivery Devices/Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pulmonary Drug Delivery Devices/Systems Product Location Distribution
3.4.2 Players Pulmonary Drug Delivery Devices/Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PULMONARY DRUG DELIVERY DEVICES/SYSTEMS BY GEOGRAPHIC REGION
4.1 World Historic Pulmonary Drug Delivery Devices/Systems Market Size by Geographic Region (2017-2022)
4.1.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue by Geographic Region
4.2 World Historic Pulmonary Drug Delivery Devices/Systems Market Size by Country/Region (2017-2022)
4.2.1 Global Pulmonary Drug Delivery Devices/Systems Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue by Country/Region
4.3 Americas Pulmonary Drug Delivery Devices/Systems Sales Growth
4.4 APAC Pulmonary Drug Delivery Devices/Systems Sales Growth
4.5 Europe Pulmonary Drug Delivery Devices/Systems Sales Growth
4.6 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Growth
5 AMERICAS
5.1 Americas Pulmonary Drug Delivery Devices/Systems Sales by Country
5.1.1 Americas Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022)
5.1.2 Americas Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022)
5.2 Americas Pulmonary Drug Delivery Devices/Systems Sales by Type
5.3 Americas Pulmonary Drug Delivery Devices/Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pulmonary Drug Delivery Devices/Systems Sales by Region
6.1.1 APAC Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022)
6.1.2 APAC Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022)
6.2 APAC Pulmonary Drug Delivery Devices/Systems Sales by Type
6.3 APAC Pulmonary Drug Delivery Devices/Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pulmonary Drug Delivery Devices/Systems by Country
7.1.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022)
7.1.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022)
7.2 Europe Pulmonary Drug Delivery Devices/Systems Sales by Type
7.3 Europe Pulmonary Drug Delivery Devices/Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pulmonary Drug Delivery Devices/Systems by Country
8.1.1 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022)
8.2 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Type
8.3 Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices/Systems
10.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices/Systems
10.4 Industry Chain Structure of Pulmonary Drug Delivery Devices/Systems
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pulmonary Drug Delivery Devices/Systems Distributors
11.3 Pulmonary Drug Delivery Devices/Systems Customer
12 WORLD FORECAST REVIEW FOR PULMONARY DRUG DELIVERY DEVICES/SYSTEMS BY GEOGRAPHIC REGION
12.1 Global Pulmonary Drug Delivery Devices/Systems Market Size Forecast by Region
12.1.1 Global Pulmonary Drug Delivery Devices/Systems Forecast by Region (2023-2028)
12.1.2 Global Pulmonary Drug Delivery Devices/Systems Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pulmonary Drug Delivery Devices/Systems Forecast by Type
12.7 Global Pulmonary Drug Delivery Devices/Systems Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hovione
13.1.1 Hovione Company Information
13.1.2 Hovione Pulmonary Drug Delivery Devices/Systems Product Offered
13.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hovione Main Business Overview
13.1.5 Hovione Latest Developments
13.2 3M Health Care
13.2.1 3M Health Care Company Information
13.2.2 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Offered
13.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 3M Health Care Main Business Overview
13.2.5 3M Health Care Latest Developments
13.3 Bespak
13.3.1 Bespak Company Information
13.3.2 Bespak Pulmonary Drug Delivery Devices/Systems Product Offered
13.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bespak Main Business Overview
13.3.5 Bespak Latest Developments
13.4 BeyonDevices
13.4.1 BeyonDevices Company Information
13.4.2 BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Offered
13.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BeyonDevices Main Business Overview
13.4.5 BeyonDevices Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Offered
13.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 H&T Presspart
13.6.1 H&T Presspart Company Information
13.6.2 H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Offered
13.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 H&T Presspart Main Business Overview
13.6.5 H&T Presspart Latest Developments
13.7 PARI Respiratory Equipment
13.7.1 PARI Respiratory Equipment Company Information
13.7.2 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Offered
13.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PARI Respiratory Equipment Main Business Overview
13.7.5 PARI Respiratory Equipment Latest Developments
13.8 Philips Respironics
13.8.1 Philips Respironics Company Information
13.8.2 Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Offered
13.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Philips Respironics Main Business Overview
13.8.5 Philips Respironics Latest Developments
13.9 SHL
13.9.1 SHL Company Information
13.9.2 SHL Pulmonary Drug Delivery Devices/Systems Product Offered
13.9.3 SHL Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 SHL Main Business Overview
13.9.5 SHL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pulmonary Drug Delivery Devices/Systems Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pulmonary Drug Delivery Devices/Systems Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Metered Dose Inhalers
Table 4. Major Players of Dry Powder Inhalers
Table 5. Major Players of Nebulizers
Table 6. Major Players of Accessories
Table 7. Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 8. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 9. Global Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & ($ million)
Table 10. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2022)
Table 11. Global Pulmonary Drug Delivery Devices/Systems Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 13. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 14. Global Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022)
Table 15. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2022)
Table 16. Global Pulmonary Drug Delivery Devices/Systems Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Pulmonary Drug Delivery Devices/Systems Sales by Company (2020-2022) & (K Units)
Table 18. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2020-2022)
Table 19. Global Pulmonary Drug Delivery Devices/Systems Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Company (2020-2022)
Table 21. Global Pulmonary Drug Delivery Devices/Systems Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Pulmonary Drug Delivery Devices/Systems Producing Area Distribution and Sales Area
Table 23. Players Pulmonary Drug Delivery Devices/Systems Products Offered
Table 24. Pulmonary Drug Delivery Devices/Systems Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pulmonary Drug Delivery Devices/Systems Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share Geographic Region (2017-2022)
Table 29. Global Pulmonary Drug Delivery Devices/Systems Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Pulmonary Drug Delivery Devices/Systems Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country/Region (2017-2022)
Table 33. Global Pulmonary Drug Delivery Devices/Systems Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 36. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country (2017-2022)
Table 37. Americas Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country (2017-2022)
Table 39. Americas Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 40. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 41. Americas Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 42. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 43. APAC Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022) & (K Units)
Table 44. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
Table 45. APAC Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region (2017-2022)
Table 47. APAC Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 48. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 49. APAC Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 50. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 51. Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 52. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country (2017-2022)
Table 53. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country (2017-2022)
Table 55. Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 56. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 57. Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 58. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Pulmonary Drug Delivery Devices/Systems
Table 68. Key Market Challenges & Risks of Pulmonary Drug Delivery Devices/Systems
Table 69. Key Industry Trends of Pulmonary Drug Delivery Devices/Systems
Table 70. Pulmonary Drug Delivery Devices/Systems Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Pulmonary Drug Delivery Devices/Systems Distributors List
Table 73. Pulmonary Drug Delivery Devices/Systems Customer List
Table 74. Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Pulmonary Drug Delivery Devices/Systems Sales Market Forecast by Region
Table 76. Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Pulmonary Drug Delivery Devices/Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Pulmonary Drug Delivery Devices/Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Pulmonary Drug Delivery Devices/Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share Forecast by Application (2023-2028)
Table 94. Hovione Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 95. Hovione Pulmonary Drug Delivery Devices/Systems Product Offered
Table 96. Hovione Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Hovione Main Business
Table 98. Hovione Latest Developments
Table 99. 3M Health Care Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 100. 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Offered
Table 101. 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. 3M Health Care Main Business
Table 103. 3M Health Care Latest Developments
Table 104. Bespak Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 105. Bespak Pulmonary Drug Delivery Devices/Systems Product Offered
Table 106. Bespak Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Bespak Main Business
Table 108. Bespak Latest Developments
Table 109. BeyonDevices Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 110. BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Offered
Table 111. BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. BeyonDevices Main Business
Table 113. BeyonDevices Latest Developments
Table 114. GlaxoSmithKline Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Offered
Table 116. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. GlaxoSmithKline Main Business
Table 118. GlaxoSmithKline Latest Developments
Table 119. H&T Presspart Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 120. H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Offered
Table 121. H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. H&T Presspart Main Business
Table 123. H&T Presspart Latest Developments
Table 124. PARI Respiratory Equipment Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 125. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Offered
Table 126. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. PARI Respiratory Equipment Main Business
Table 128. PARI Respiratory Equipment Latest Developments
Table 129. Philips Respironics Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 130. Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Offered
Table 131. Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Philips Respironics Main Business
Table 133. Philips Respironics Latest Developments
Table 134. SHL Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 135. SHL Pulmonary Drug Delivery Devices/Systems Product Offered
Table 136. SHL Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. SHL Main Business
Table 138. SHL Latest Developments
Table 1. Pulmonary Drug Delivery Devices/Systems Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pulmonary Drug Delivery Devices/Systems Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Metered Dose Inhalers
Table 4. Major Players of Dry Powder Inhalers
Table 5. Major Players of Nebulizers
Table 6. Major Players of Accessories
Table 7. Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 8. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 9. Global Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & ($ million)
Table 10. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2022)
Table 11. Global Pulmonary Drug Delivery Devices/Systems Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 13. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 14. Global Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022)
Table 15. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2022)
Table 16. Global Pulmonary Drug Delivery Devices/Systems Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Pulmonary Drug Delivery Devices/Systems Sales by Company (2020-2022) & (K Units)
Table 18. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Company (2020-2022)
Table 19. Global Pulmonary Drug Delivery Devices/Systems Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Company (2020-2022)
Table 21. Global Pulmonary Drug Delivery Devices/Systems Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Pulmonary Drug Delivery Devices/Systems Producing Area Distribution and Sales Area
Table 23. Players Pulmonary Drug Delivery Devices/Systems Products Offered
Table 24. Pulmonary Drug Delivery Devices/Systems Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pulmonary Drug Delivery Devices/Systems Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share Geographic Region (2017-2022)
Table 29. Global Pulmonary Drug Delivery Devices/Systems Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Pulmonary Drug Delivery Devices/Systems Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country/Region (2017-2022)
Table 33. Global Pulmonary Drug Delivery Devices/Systems Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 36. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country (2017-2022)
Table 37. Americas Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country (2017-2022)
Table 39. Americas Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 40. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 41. Americas Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 42. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 43. APAC Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022) & (K Units)
Table 44. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
Table 45. APAC Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region (2017-2022)
Table 47. APAC Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 48. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 49. APAC Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 50. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 51. Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 52. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country (2017-2022)
Table 53. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country (2017-2022)
Table 55. Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 56. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 57. Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 58. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Pulmonary Drug Delivery Devices/Systems
Table 68. Key Market Challenges & Risks of Pulmonary Drug Delivery Devices/Systems
Table 69. Key Industry Trends of Pulmonary Drug Delivery Devices/Systems
Table 70. Pulmonary Drug Delivery Devices/Systems Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Pulmonary Drug Delivery Devices/Systems Distributors List
Table 73. Pulmonary Drug Delivery Devices/Systems Customer List
Table 74. Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Pulmonary Drug Delivery Devices/Systems Sales Market Forecast by Region
Table 76. Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Pulmonary Drug Delivery Devices/Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Pulmonary Drug Delivery Devices/Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Pulmonary Drug Delivery Devices/Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Pulmonary Drug Delivery Devices/Systems Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share Forecast by Application (2023-2028)
Table 94. Hovione Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 95. Hovione Pulmonary Drug Delivery Devices/Systems Product Offered
Table 96. Hovione Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Hovione Main Business
Table 98. Hovione Latest Developments
Table 99. 3M Health Care Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 100. 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Offered
Table 101. 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. 3M Health Care Main Business
Table 103. 3M Health Care Latest Developments
Table 104. Bespak Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 105. Bespak Pulmonary Drug Delivery Devices/Systems Product Offered
Table 106. Bespak Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Bespak Main Business
Table 108. Bespak Latest Developments
Table 109. BeyonDevices Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 110. BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Offered
Table 111. BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. BeyonDevices Main Business
Table 113. BeyonDevices Latest Developments
Table 114. GlaxoSmithKline Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 115. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Offered
Table 116. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. GlaxoSmithKline Main Business
Table 118. GlaxoSmithKline Latest Developments
Table 119. H&T Presspart Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 120. H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Offered
Table 121. H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. H&T Presspart Main Business
Table 123. H&T Presspart Latest Developments
Table 124. PARI Respiratory Equipment Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 125. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Offered
Table 126. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. PARI Respiratory Equipment Main Business
Table 128. PARI Respiratory Equipment Latest Developments
Table 129. Philips Respironics Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 130. Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Offered
Table 131. Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Philips Respironics Main Business
Table 133. Philips Respironics Latest Developments
Table 134. SHL Basic Information, Pulmonary Drug Delivery Devices/Systems Manufacturing Base, Sales Area and Its Competitors
Table 135. SHL Pulmonary Drug Delivery Devices/Systems Product Offered
Table 136. SHL Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. SHL Main Business
Table 138. SHL Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pulmonary Drug Delivery Devices/Systems
Figure 2. Pulmonary Drug Delivery Devices/Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Drug Delivery Devices/Systems Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pulmonary Drug Delivery Devices/Systems Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pulmonary Drug Delivery Devices/Systems Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Metered Dose Inhalers
Figure 10. Product Picture of Dry Powder Inhalers
Figure 11. Product Picture of Nebulizers
Figure 12. Product Picture of Accessories
Figure 13. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2021
Figure 14. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2022)
Figure 15. Pulmonary Drug Delivery Devices/Systems Consumed in Hospitals and Clinics
Figure 16. Global Pulmonary Drug Delivery Devices/Systems Market: Hospitals and Clinics (2017-2022) & (K Units)
Figure 17. Pulmonary Drug Delivery Devices/Systems Consumed in Homecare
Figure 18. Global Pulmonary Drug Delivery Devices/Systems Market: Homecare (2017-2022) & (K Units)
Figure 19. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Figure 20. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application in 2021
Figure 21. Pulmonary Drug Delivery Devices/Systems Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Company in 2021
Figure 23. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Geographic Region in 2021
Figure 25. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
Figure 26. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country/Region in 2021
Figure 27. Americas Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 28. Americas Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 29. APAC Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 30. APAC Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 31. Europe Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 32. Europe Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 35. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country in 2021
Figure 36. Americas Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country in 2021
Figure 37. United States Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region in 2021
Figure 42. APAC Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Regions in 2021
Figure 43. China Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country in 2021
Figure 50. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country in 2021
Figure 51. Germany Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country in 2021
Figure 58. Egypt Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices/Systems in 2021
Figure 64. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices/Systems
Figure 65. Industry Chain Structure of Pulmonary Drug Delivery Devices/Systems
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Pulmonary Drug Delivery Devices/Systems
Figure 2. Pulmonary Drug Delivery Devices/Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pulmonary Drug Delivery Devices/Systems Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pulmonary Drug Delivery Devices/Systems Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pulmonary Drug Delivery Devices/Systems Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Metered Dose Inhalers
Figure 10. Product Picture of Dry Powder Inhalers
Figure 11. Product Picture of Nebulizers
Figure 12. Product Picture of Accessories
Figure 13. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type in 2021
Figure 14. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2022)
Figure 15. Pulmonary Drug Delivery Devices/Systems Consumed in Hospitals and Clinics
Figure 16. Global Pulmonary Drug Delivery Devices/Systems Market: Hospitals and Clinics (2017-2022) & (K Units)
Figure 17. Pulmonary Drug Delivery Devices/Systems Consumed in Homecare
Figure 18. Global Pulmonary Drug Delivery Devices/Systems Market: Homecare (2017-2022) & (K Units)
Figure 19. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2022)
Figure 20. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application in 2021
Figure 21. Pulmonary Drug Delivery Devices/Systems Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Company in 2021
Figure 23. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Geographic Region in 2021
Figure 25. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
Figure 26. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country/Region in 2021
Figure 27. Americas Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 28. Americas Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 29. APAC Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 30. APAC Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 31. Europe Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 32. Europe Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue 2017-2022 ($ Millions)
Figure 35. Americas Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country in 2021
Figure 36. Americas Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country in 2021
Figure 37. United States Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region in 2021
Figure 42. APAC Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Regions in 2021
Figure 43. China Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country in 2021
Figure 50. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country in 2021
Figure 51. Germany Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Country in 2021
Figure 58. Egypt Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Pulmonary Drug Delivery Devices/Systems Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices/Systems in 2021
Figure 64. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices/Systems
Figure 65. Industry Chain Structure of Pulmonary Drug Delivery Devices/Systems
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
